Fractyl Health (NASDAQ: $GUTS) today announced positive early data from the REVEAL-1 cohort of the ongoing REMAIN-1 pivotal study. Results show that the Revita® procedure – designed to address a root cause of obesity – has the potential to prevent weight regain after GLP-1 drug

Extra-wide spectator seating. Bariatric ambulances. Oversized coffins. With more than half of the world’s population expected to have obesity by 2050, this @guardian article paints a sobering picture of how stadiums, hospitals, airlines and other industries are adapting to the.

Did you know that #obesity disproportionately impacts women?. Nearly 42% of adult women in the U.S. live with obesity, placing them at increased risk for conditions like #heartdisease, #diabetes, and certain #cancers. Raising awareness and advancing solutions are essential steps.

Tune in now: #FractylHealthNews #FractylForward.

We’re breaking the pattern of #obesity and #T2D. Read more about Fractyl Health’s (#NASDAQ: $GUTS) Q4 and Full Year 2024 financial results and our potentially novel approach to weight maintenance here: #FractylHealthNews #FractylForward.

UPCOMING: We’re pleased to share our Q4 and full year 2024 #earnings on Monday, March 3, at 4:30 PM ET. Join us for the live webcast: . #NASDAQ: $GUTS #FractylForward

BREAKING: We're excited to announce promising initial clinical results from the first patient in the REVEAL-1 open-label cohort of our REMAIN-1 study. We're seeing positive results after one month of #GLP1 drug discontinuation alongside the Revita procedure, in line with trends.

We look forward to connecting with industry peers and learning about the latest insights in #healthcare at @jpmorgan’s 43rd Annual Healthcare Conference in San Francisco! We hope to see you there. $GUTS #FractylForward #JPM2025.

We’ve had a banner year at Fractyl Health. From going public, to presenting compelling data across the country to investors and scientists and receiving a Breakthrough Device designation from the FDA - we're celebrating our successes and looking #FractylForward to a big 2025 full

We presented exciting new #Rejuva data at @WCIRDC last week. Thank you to all who attended our session. We hope to continue sharing this compelling data with our community!. *Rejuva is in preclinical development and has yet to be assessed by regulatory agencies. $GUTS

We’re living our passion of developing breakthrough therapies to improve lives every day. See how Krysta Banfield, Diabetes Educator, finds innovative solutions for people living with #obesity and #T2D. #FractylForward

We’re breaking the pattern of #obesity and #T2D. Read more about Fractyl Health’s (#NASDAQ: $GUTS) Q3 financial results and our potentially novel approach to weight maintenance here: #FractylHealthNews

We were thrilled to share our latest research at @ObesityWeek and connect with brilliant minds dedicated to tackling #obesity and #T2D. Thank you to everyone who joined our presentations and engaged in insightful discussions!. Read more: #OW2024

We’re at @ObesityWeek this week learning and sharing the latest updates in the #obesity space. We’re excited to be connecting with our industry peers and look forward to celebrating the industry’s momentum this week! #OW2024

We are excited to announce that Fractyl Health will be presenting cutting-edge research at @ObesityWeek in San Antonio, TX. Join us for our oral and poster presentations where we'll share the latest advancements in tackling the unmet need in obesity – durable weight maintenance.

We've got some exciting news. we're rolling out a refreshed brand identity and website! Our rebrand is a pivotal moment, reflecting the transition of Fractyl Health: who we are, where we’re headed, & our commitment to our patients. See our new look at

See what motivates Sam Berard, Senior Manufacturing Engineer, at work every day. #FractylForward

At Fractyl Health, our mission is to innovate new solutions for people living with #obesity and #T2D. For Emily Sorrentine, Associate Director, Procedural Training, Medical Affairs, the people she works with each day are a testament to Fractyl Health’s approach and values.

Last week, our CEO, @therealharith, showcased our latest #obesity and #T2D care innovations with fellow industry leaders at the @MorganStanley Laguna Conference and the @HCWCO #HCWainwrightGlobal Conference. We look forward to next year’s meetings!